Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 50Breast Neoplasms 25Neoplasms 6Neoplasm Metastasis 3Prostate Adenocarcinoma 2Breast Neoplasms, Male 2Advanced Breast Cancer 2Recurrence 1Primary Ovarian Insufficiency 1PSA Level Greater Than Two 1Osteitis Deformans 1Lymphatic Metastasis 1Infertility 1Hormone-sensitive Metastatic Breast Cancer 1Hormone Sensitive Prostate Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Advanced Metastatic Breast Cancer 1

Interventions

luprolide acetate gel depot 1bicalutamide 1Radiotherapy, Intensity-Modulated 1Leuprolide 1Goserelin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × PSA Level Greater Than Two × Goserelin × Clear all
NCT00544830 2026-05-15

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
29 enrolled 12 charts
Genitourinary

PSA Level Greater Than Two

Data powered by HemOnc (CC BY 4.0) Colophon âš¡